Kaskela Law is investigating the $9.50 per share buyout offer for Global Business Travel Group (GBTG), arguing it may undervalue the shares. The firm notes that some analysts had price targets as high as $12 per share, about 25% above the buyout price. Investors are encouraged to contact Kaskela Law to explore legal options to seek a better deal before the privatization completes and GBTG shares are delisted from the NYSE.
Constellium has sold its stake in the automotive structures joint venture located in Changchun, China, to a Chinese automotive holding company. The facility, which employs about 200 people, produces aluminum crash management systems and structural co...
MEXC has launched the TradFi Gala, a month-long Futures trading campaign from June 26 to July 26, 2026, featuring 0-fee trading and a 1,000,000 USDT reward pool. The campaign targets AI and semiconductor stock trading, reflecting strong market moment...
Zymeworks Inc. announced it will acquire Theravance Biopharma for approximately $929 million in cash, adding the COPD treatment YUPELRI to its portfolio. The acquisition is expected to enhance Zymeworks' earnings and cash flow, supported by a $350 mi...
McEwen Inc. has been added to the Russell 2000 Index as of June 29, 2026, following the Russell Reconstitution. This inclusion increases McEwen's visibility to institutional investors and index-tracking funds. The company focuses on gold, silver, and...
Global Net Lease, Inc. has sold $74 million in assets since Q1 2026, including $66 million of occupied properties mainly office assets at a 7.2% cash cap rate. These sales reduce the company's office property exposure to about 21% of portfolio rent, ...
